Table 2 Antimicrobial susceptibility testing data according to EUCAST for all patient and environmental isolates. Minimum inhibitory concentrations are indicated in brackets. n.d.: not determined
Antibiotic | Patient A | Patient B | Patient C | Patient D | Patient E | Patient F | Patient G | Room 1–1 | Room 1–2 | Room 1–3 | Room 2–1 | Room 3–1 | Room 4–1 | Room 5–1 | Room 6–1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ampicillin | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
Amoxicillin/clavulanic acid | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
Cefuroxime | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
Cefotaxime | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
Ceftazidime | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
Cefepime | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
Ceftolozane-Tazobactam | R | R | R | R | R | R | R | n.d | n.d | n.d | n.d | n.d | n.d | n.d | n.d |
Ceftazidime-Avibactam | R | R | R | R | R | R | R | n.d | n.d | n.d | n.d | n.d | n.d | n.d | n.d |
Meropenem | R [16] | R [16] | R [16] | R [16] | R [16] | R [16] | I [8] | I | R | I | R | R | I | I | R |
Gentamicin | S | S | R | S | S | I | S | S | S | S | R | S | S | S | R |
Tobramycin | R | R | R | R | R | R | R | n.d | n.d | n.d | n.d | n.d | n.d | n.d | n.d |
Amikacin | S | S | S | S | S | I | S | n.d | n.d | n.d | n.d | n.d | n.d | n.d | n.d |
Ciprofloxacin | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
Fosfomycin | S [2] | S [1] | S [1] | S [0.5] | S [0.5] | S [4] | S [1] | n.d | n.d | n.d | n.d | n.d | n.d | n.d | n.d |
Tigecyclin | S [0.25] | S [0.125] | S [0.5] | S [0.25] | S [0.125] | S [0.25] | S [0.25] | n.d | n.d | n.d | n.d | n.d | n.d | n.d | n.d |
Trimethoprim-Sulfamethoxazole | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
Colistin | S [0.25] | S [0.25] | S [0.25] | S [0.25] | S [0.25] | S [1] | S [1] | n.d | S [1] | n.d | n.d | n.d | n.d | n.d | S [1] |